Skip to Main Content

Paper Details

Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.
Cell Genom
28
2022
Author NameAffiliation
Chantal PauliUniversity Hospital Zurich
  • 1 - 1

Datasets

Release 1.2